Elite Pharmaceuticals Inc (ELTP)
0.139
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
Elite Pharmaceuticals Enterprise Value: 143.28M for May 16, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 16, 2024 | 143.28M |
| May 15, 2024 | 144.19M |
| May 14, 2024 | 143.79M |
| May 13, 2024 | 139.82M |
| May 10, 2024 | 139.82M |
| May 09, 2024 | 130.30M |
| May 08, 2024 | 136.15M |
| May 07, 2024 | 139.21M |
| May 06, 2024 | 147.86M |
| May 03, 2024 | 133.93M |
| May 02, 2024 | 133.28M |
| May 01, 2024 | 133.23M |
| April 30, 2024 | 133.80M |
| April 29, 2024 | 139.21M |
| April 26, 2024 | 136.66M |
| April 25, 2024 | 133.61M |
| April 24, 2024 | 130.35M |
| April 23, 2024 | 127.20M |
| April 22, 2024 | 131.27M |
| April 19, 2024 | 134.12M |
| April 18, 2024 | 137.68M |
| April 17, 2024 | 140.02M |
| April 16, 2024 | 139.46M |
| April 15, 2024 | 139.21M |
| April 12, 2024 | 144.30M |
| Date | Value |
|---|---|
| April 11, 2024 | 144.17M |
| April 10, 2024 | 145.01M |
| April 09, 2024 | 145.26M |
| April 08, 2024 | 143.02M |
| April 05, 2024 | 144.30M |
| April 04, 2024 | 142.06M |
| April 03, 2024 | 144.30M |
| April 02, 2024 | 157.53M |
| April 01, 2024 | 157.53M |
| March 28, 2024 | 158.89M |
| March 27, 2024 | 157.53M |
| March 26, 2024 | 156.87M |
| March 25, 2024 | 156.31M |
| March 22, 2024 | 155.70M |
| March 21, 2024 | 157.38M |
| March 20, 2024 | 153.46M |
| March 19, 2024 | 146.43M |
| March 18, 2024 | 148.37M |
| March 15, 2024 | 148.35M |
| March 14, 2024 | 143.28M |
| March 13, 2024 | 142.77M |
| March 12, 2024 | 138.19M |
| March 11, 2024 | 149.49M |
| March 08, 2024 | 156.51M |
| March 07, 2024 | 158.55M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
25.44M
Minimum
Mar 31 2023
210.45M
Maximum
Jan 23 2024
66.14M
Average
56.47M
Median
Jul 31 2019
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 5.209M |
| Palatin Technologies Inc | 23.43M |
| iBio Inc | 16.17M |
| Theriva Biologics Inc | -8.844M |
| Oragenics Inc | 5.770M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 0.7064M |
| Revenue (Quarterly) | 15.54M |
| Total Expenses (Quarterly) | 12.01M |
| EPS Diluted (Quarterly) | 0.0007 |
| Gross Profit Margin (Quarterly) | 45.31% |
| Profit Margin (Quarterly) | 4.55% |
| Earnings Yield | 7.62% |
| Operating Earnings Yield | 4.92% |
| Normalized Earnings Yield | 9.730 |